<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03090828</url>
  </required_header>
  <id_info>
    <org_study_id>*P150958</org_study_id>
    <nct_id>NCT03090828</nct_id>
  </id_info>
  <brief_title>Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease</brief_title>
  <acronym>PIC-R</acronym>
  <official_title>Economic Evaluation of an Interactive Community-based Patient Education Platform Kidney Dialysis and Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Leon Berard</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Montpellier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Telecom Bretagne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Paris School of economics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1600 patients with severe, end stage renal disease or post transplant will be randomised
      1:1:1 to either standard therapeutic education; or education using a specific app; or the
      enhanced interactive app using feedback messages.

      The total follow up duration is 18 months. Primary endpoint is the cost utility of using
      app-based therapeutic intervention, secondary endpoints are: compliance with treatment
      guidelines, app use (professionals and patients), budget impact analysis
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cost utility, efficiency, budget impact</measure>
    <time_frame>18 months</time_frame>
    <description>incremental cost utility ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>18 months</time_frame>
    <description>percent of patients alive at 18 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>compliance and persistence</measure>
    <time_frame>18 months</time_frame>
    <description>percent of patients using the app at 18 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>disease knowledge</measure>
    <time_frame>18 months</time_frame>
    <description>answers to a questionnaire and change in the number of correct answers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lifestyle</measure>
    <time_frame>18 months</time_frame>
    <description>changes in risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>app utilization by professionals and patients</measure>
    <time_frame>18 months</time_frame>
    <description>number of connections, shares, likes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>health care delivery organization</measure>
    <time_frame>18 months</time_frame>
    <description>number of interactions (chats) between healthcare professionals and patients</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>End-stage Renal Disease</condition>
  <condition>Dialysis</condition>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>treatment as usual will be provided to patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>app-based therapeutic education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will have access to the app providing information of the disease as well as educational guidelines</description>
  </arm_group>
  <arm_group>
    <arm_group_label>enhanced app-based therapeutic education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will also have access to a chat room and discussion forum</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>app-based therapeutic education</intervention_name>
    <description>Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.</description>
    <arm_group_label>app-based therapeutic education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>enhanced app-based therapeutic education</intervention_name>
    <description>Patients in the enhanced app group will also have access to a social network. (forum, chat room)</description>
    <arm_group_label>enhanced app-based therapeutic education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  severe end-stage renal disease Internet, literacy informed consent

        Exclusion Criteria:

          -  did not fill the screening questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 21, 2017</last_update_submitted>
  <last_update_submitted_qc>March 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>economic evaluation</keyword>
  <keyword>e health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>JPAL plans to share the de-identified patient database</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

